| MDH | Mammary ductal hyperplasia |
| DCIS | ductal carcinoma in situ |
| RR | relative risk |
| UDH | usual ductal hyperplasia |
| OR | odds ratio |
| ADH | atypical ductal hyperplasia |
| ALH | atypical lobular hyperplasia |
| FEA | flat epithelial atypia |
| MRI | Magnetic Resonance Imaging |
| LCIS | lobular in situ carcinoma |
| PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| BRCA1/2 | Breast CAncer gene 1/2 |
| TP53 | Tumor Protein 53 |
| DNA | Deoxyribonucleic Acid |
| K-AKT-mTOR | Phosphoinositide 3-kinase-AKR mouse thymoma-Mechanistic (mammalian) Target of Rapamycin |
| CDH1 | Cadherin-1 |
| TBX3 | T-box transcription factor 3 |
| CCLs | Columnar cell lesions |
| ER | Estrogen Receptor |
| NF1 | Neurofibromin 1 |
| GATA | Glutamyl aminotransferase subunit A |
| MAP3K1 | Mitogen-activated protein kinase kinase kinase 1 |
| CBFB | Core-Binding Factor, Beta Subunit |
| 16q LOH | 16 q Loss of Heterozygosity |
| PTEN | phosphatase and tensin homolog |
| IBC | invasive breast cancers |
| ERBB2 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
| HR | hormone receptors |
| RUNX1 | Runt-related transcription factor 1 |
| FOXA1 | Forkhead box protein A1 |
| KMT2C (MLL3)/KMT2D (MLL2) | type 2 lysine methyltransferases |
| ARID 1A/ARID 1B | AT-Rich Interaction Domain 1A Gene/AT-Rich Interaction Domain 1B Gene |
| NCOR1/NCOR2 | Nuclear Receptor Co-Repressor 1/Nuclear Receptor Co-Repressor 2 |
| CREBBP/EP300 | CAMP Response Element-Binding-Binding Protein/E1A-binding protein P300 |
| NOTCH1 | Neurogenic locus notch homolog protein 1 |
| RNAs | Ribonucleic acid |
| RASSF1A | Ras Association Domain Family 1, isoform A |
| APC | Adenomatous Polyposis Coli |
| TWIST1 | Twist Family BHLH Transcription Factor 1 |
| HIN1 | Hypermethylated in Cancer 1 |
| p16INK4a | Cyclin-Dependent Kinase Inhibitor 2A |
| TP53 | Tumor Protein p53 |
| SOCS1 | Suppressor of Cytokine Signaling 1 |
| CGH | Comparative genomic hybridization |
| FISH | Fluorescence in situ hybridization |
| HER 2 | Human Epidermal Growth Factor Receptor 2 |
| IHC | Immunohistochemistry |
| MMP-1 | Matrix metalloproteinase-1 |
| PAS | periodic acid-Schiff |
| RRM2 | Ribonucleotide Reductase Regulatory Subunit M2 |
| TOP2A | Topoisomerase II Alpha |
| PBK | PDZ-Binding Kinase |
| MELK | Maternal Embryonic Leucine Zipper Kinase |
| NUSAP1 | Nucleolar and Spindle-Associated Protein 1 |
| AH | atypical hyperplasia |
| H-E | haematoxylin and eosin |
| PCR | polymerase chain reaction |
| HIF-1alpha | Hypoxia-Inducible Factor 1 alpha |
| GLUT1 | Glucose Transporter 1 |
| CAIX | Carbonic Anhydrase IX |
| JAG1 | Jagged 1 |
| RB | Retinoblastoma protein |
| LOH | Loss of heterozygosity |
| TNM | Tumor–Node–Metastasis staging system |
| SMA | and smooth muscle actin |
| CK5/6 | Cytokeratin 5/6 |
| FHIT | Fragile Histidine Triad |
| WWOX | WW Domain–Containing Oxidoreductase |
| CGH | Comparative Genomic Hybridization. |
| c-erbB-2 | HER2 |
| SIR | Signal-to-Intensity Ratio |
| ESR1 | Estrogen receptor 1 |
| PGR | Progesterone receptor |
| Ki-67 | Tumor proliferation |
| EMT | epithelial-to-mesenchymal transition |
| Wnt | Wingless Int-1 |
| LOI | Loss of imprinting |
| H3K27me3 | Histone 3 lysine 27 trimethylation |
| HM13 | Histocompatibility minor 13 |
| KCNQ9 | Potassium voltage-gated channel subfamily Q member 9 |
| IGF2 | Insulin-like growth factor 2 |
| PEG1/MEST | Paternally expressed gene 1/Mesoderm-specific transcript |
| TASK3 | TWIK-related acid-sensitive potassium channel 3 |
| KCNK9 DMR | Potassium channel subfamily K member 9 differentially methylated region |
| TGF-β | Transforming Growth Factor beta |
| BMP | Bone Morphogenetic Protein |
| DDL | Delta-like ligand (DLL) |
| SOX2 | SRY (Sex-determining Region Y)-Box 2 |
| OCT4 | Octamer-binding transcription factor 4 |
| CSCs | cancer stem cells |
| IL-6 | Interleukin 6 |
| PKB | Protein Kinase B (also known as AKT) |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| MRP2 | Multidrug Resistance-associated Protein 2 |
| CTNNB1 | Catenin Beta 1 (β-catenin) |
| AXIN | Axis Inhibition Protein |
| SFRP1-5 | Secreted Frizzled-Related Proteins 1–5 |
| WIF1 | Wnt Inhibitory Factor 1 |
| DKK1 | Dickkopf-related protein 1 |
| SRY | Sex-determining Region Y |
| EZH2 | Enhancer of Zeste Homolog 2 |
| DACT3 | Disheveled-binding Antagonist of β-catenin 3 |
| H3K4me3 | Histone 3 lysine 4 trimethylation |
| Suz12 | Suppressor of Zeste 12 |
| SirT1 | Sirtuin 1 |
| BMI1 | B lymphoma Mo-MLV insertion region 1 homolog |
| Lef1 | Lymphoid Enhancer-binding Factor 1 |
| Slug | Snail family transcriptional repressor 2 |
| ZEB1 | Zinc Finger E-box-binding Homeobox 1 |
| Snail | Snail family transcriptional repressor 1 |
| ZEB2 | Zinc Finger E-box-binding Homeobox 2 |
| FOXC2 | Forkhead Box C2 |
| TWIST2 | Twist family bHLH transcription factor 2 |
| CD44 | Cluster of Differentiation 44 |
| CD133 | Cluster of Differentiation 133 |
| SIP1 | Smad Interacting Protein 1 |
| BMP-6 | Bone Morphogenetic Protein 6 |
| ECM | extracellular matrix |
| TME | tumor microenvironment |
| α-SMA | alpha-smooth muscle actin |
| CAFs | cancer-associated fibroblasts |
| HGF | hepatocyte growth factor |
| MET receptor | Mesenchymal–Epithelial Transition receptor |
| MCF10 | original non-tumorigenic human mammary epithelial cell line |
| HGF/MET | Hepatocyte Growth Factor/MET receptor signaling pathway |
| HFD | high-fat diet |
| CEACAM1 | in carcinoembryonic antigen-related cell adhesion molecule 1 |
| MVD | Microvessel Density |
| PKC-α | Protein Kinase C alpha |
| MEK3 | Mitogen-activated protein kinase kinase 3 |
| AMPKα | AMP-activated protein kinase alpha subunit |
| TILs | tumor-infiltrating lymphocytes |
| Foxp3 | Forkhead box P3 |
| Tregs | regulatory T cells |
| S100A9 | S100 calcium-binding protein A9 |
| PMN | polymorphonuclear neutrophils |
| Ly6G+ | Lymphocyte antigen 6 complex, locus G positive |
| HIF 1α | 1hypoxia-inducible factor-1α |
| VEGF | vascular endothelial growth factor |
| DCE-MRI | Dynamic contrast-enhanced MRI |
| sEVs | small extracellular vesicles |
| PMN-MDSCs | polymorphonuclear myeloid-derived suppressor cells |
| IGF | Insulin-like growth factor |
| MAPK | Mitogen-Activated Protein Kinase |
| ET | Endocrine Therapy |
| ROS | reactive oxygen species |
| GPER | G protein-coupled estrogen receptor |
| EDCs | Endocrine-disrupting chemicals |
| BPA | Bisphenol A |
| DDT | Dichlorodiphenyltrichloroethane |
| CYP19A1 | Cytochrome P450 Family 19 Subfamily A Member 1 |
| PM | particulate matter |
| PAHs | polycyclic aromatic hydrocarbons |